Trademark: EXELTIS 1586459
Word
EXELTIS
ID
1586459
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
19 June 2013
Registration Date
19 June 2013
Renewal Date
05 March 2032

Service
AJ Park

Goods and Services:
Class 5:
Pharmaceutical preparations for use in the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, digestive diseases and disorders, gynecological diseases and disorders; reagents for use in pregnancy tests; reagents for use in ovulation tests; reagents for use in testing for diabetes; contraceptives; pharmaceutical preparations for use in the treatment of hormonal diseases and disorders, blood disorders, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders; pharmaceutical preparations for use in treating diseases of the musculoskeletal system, diseases of the respiratory system, diseases of the circulatory system, viral diseases, glaucoma, dental and oral diseases, obesity, cholesterol in diseases of the liver; nutraceutical products; pharmaceutical preparations for the treatment of blood pressure and rheumatism; veterinary preparations for the treatment of digestive diseases and disorders, gynecological diseases and disorders, blood disorders, the treatment of cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological diseases, infectious diseases, inflammatory diseases, diseases and disorders of the metabolism, of the musculoskeletal system, the respiratory system and the circulatory system, the treatment of viral diseases, glaucoma, oral and dental diseases, obesity, liver disease, cholesterol; nutraceutical veterinary preparations; veterinary preparations for the treatment of blood pressure and for rheumatism; and dietetic foods for medical use; excluded from this class are surgical implants - living tissues, human organs and parts thereof, human tissue and pharmaceutical products for cancer and oncological purposes, and pharmaceuticals in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease